These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 1723815

  • 1. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF, Bentvelsen FM, Oosterom R, Schroeder FH.
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [Abstract] [Full Text] [Related]

  • 2. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM, Bogdanowicz JF, Oosterom R, Schröder FH.
    Ned Tijdschr Geneeskd; 1990 Aug 18; 134(33):1596-600. PubMed ID: 1697651
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E.
    N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609
    [Abstract] [Full Text] [Related]

  • 4. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Oct 08; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

  • 5. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug 08; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 6. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Aug 08; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 7. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S, Skaarland E, Halvorsen OJ, Stensland E, Farstad M.
    Tidsskr Nor Laegeforen; 1990 Sep 30; 110(23):2990-3. PubMed ID: 1700496
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 30; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
    Barak M, Mecz Y, Lurie A, Gruener N.
    J Lab Clin Med; 1989 May 30; 113(5):598-603. PubMed ID: 2469756
    [Abstract] [Full Text] [Related]

  • 10. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H, Tsuka H, Okada K, Tsuchiya Y, Matsubara M, Arimura K.
    Hinyokika Kiyo; 1995 Jun 30; 41(6):439-45. PubMed ID: 7544063
    [Abstract] [Full Text] [Related]

  • 11. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P, Rymer JC, Chopin D, Kouyoudjian JC, Abbou CC, Auvert J.
    Ann Urol (Paris); 1988 Jun 30; 22(3):199-205. PubMed ID: 2456713
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F, Zambolin T, Bonora R, Panteghini M.
    J Nucl Med Allied Sci; 1990 Jun 30; 34(4 Suppl):85-7. PubMed ID: 1709211
    [Abstract] [Full Text] [Related]

  • 13. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J, Chevallier D, Peyrottes A, Benoliel J, Toubol J.
    Ann Urol (Paris); 1989 Jun 30; 23(6):528-30. PubMed ID: 2482700
    [Abstract] [Full Text] [Related]

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct 30; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study of tumor markers in prostatic cancer].
    Ishihara Y, Fukagai T, Ohta K, Hiromoto Y, Hiramori M, Torii T, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1990 Apr 30; 36(4):425-31. PubMed ID: 1696063
    [Abstract] [Full Text] [Related]

  • 16. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A.
    Scand J Urol Nephrol Suppl; 1994 Apr 30; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [Abstract] [Full Text] [Related]

  • 17. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M.
    Anticancer Res; 1993 Apr 30; 13(3):769-77. PubMed ID: 7686362
    [Abstract] [Full Text] [Related]

  • 18. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
    Wang TY, Kawaguchi TP.
    Ann Clin Lab Sci; 1986 Apr 30; 16(6):461-6. PubMed ID: 3800301
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Feb 30; 46(2):145-54. PubMed ID: 9135695
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y, Yoshki T, Okada K, Yoshida O, Yamamoto N, Sakatoku J, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 1989 Sep 30; 35(9):1519-28. PubMed ID: 2479237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.